Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Comparing Efficacy & Safety of Tacrolimus & MMF With/Without Induction in the Elderly Following Kidney Transplantation. (SENIOR)

This study has been completed.
Astellas Pharma Europe B.V.
Information provided by (Responsible Party):
Astellas Pharma Inc Identifier:
First received: February 23, 2006
Last updated: August 28, 2014
Last verified: August 2014
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: August 2006
  Primary Completion Date: August 2006 (Final data collection date for primary outcome measure)